Teacher
Professional
- Messages
- 2,670
- Reaction score
- 783
- Points
- 113
Will China be able to use the sensitive data of Americans to achieve its own interests?
U.S. lawmakers are pushing for a bill that would restrict U.S. companies from doing business with Chinese biotech companies. The reason was fears that sensitive medical data of Americans could be used by Beijing for malicious purposes.
Over the past year, Chinese technology, hackers, drones, automakers, TikTok, and now biotech companies have drawn attention to US national security. Companies owned or controlled by the Chinese Communist Party (CCP) were targeted, with a particular focus on collecting genomic data from Americans.
The U.S. House of Representatives on CPC issues held a hearing on the issue, following the Senate Homeland Security Committee's approval of a bill banning federal funding for Chinese biotech companies that pose a national security threat.
The" Foreign Access Ban on American Genetic Information Act of 2024 " is aimed at preventing Chinese companies from obtaining American finance through federal contracts, grants, and loans.
Senator Bill Hagerty, one of the co-authors of the bill, expressed concern about China's creation of a global DNA database. It is noted that such genetic data can be used for military purposes, for violating personal life, creating viral pathogens and violating human rights.
According to Mike Gallagher, Chairman of the House Committee on the CCP, the CCP seeks to create a global DNA database on the planet, including Americans, through hacking, corporate purchases and other methods.
Chinese biotech companies, including BGI Group and WuXi AppTec, are actively collecting genetic data, according to the US government, which has caused concern in the US.
Critics point to the unfair targeting of China, highlighting the possible consequences for the biotech supply chain and markets. However, despite concerns, the bill has every chance of being adopted.
The Chinese side, represented by Liu Pengyu, a representative of the Chinese Embassy in the United States, denies any accusations of stealing genetic data, calling them baseless and far-fetched.
Meanwhile, Republican Senator Rand Paul became the only U.S. official to vote against the bill, expressing the view that it uses anti-Chinese sentiment to achieve U.S. goals.
Thus, America needs to find a balance between protecting national security and remaining open to international cooperation in the field of biotechnology.
While it may be justified to restrict access to genetic data, excessive suspicion can harm scientific progress and global partnerships.
Only a reasonable approach, taking into account real threats, without excessive paranoia, will protect sensitive information and at the same time will not slow down the development of a promising industry.
U.S. lawmakers are pushing for a bill that would restrict U.S. companies from doing business with Chinese biotech companies. The reason was fears that sensitive medical data of Americans could be used by Beijing for malicious purposes.
Over the past year, Chinese technology, hackers, drones, automakers, TikTok, and now biotech companies have drawn attention to US national security. Companies owned or controlled by the Chinese Communist Party (CCP) were targeted, with a particular focus on collecting genomic data from Americans.
The U.S. House of Representatives on CPC issues held a hearing on the issue, following the Senate Homeland Security Committee's approval of a bill banning federal funding for Chinese biotech companies that pose a national security threat.
The" Foreign Access Ban on American Genetic Information Act of 2024 " is aimed at preventing Chinese companies from obtaining American finance through federal contracts, grants, and loans.
Senator Bill Hagerty, one of the co-authors of the bill, expressed concern about China's creation of a global DNA database. It is noted that such genetic data can be used for military purposes, for violating personal life, creating viral pathogens and violating human rights.
According to Mike Gallagher, Chairman of the House Committee on the CCP, the CCP seeks to create a global DNA database on the planet, including Americans, through hacking, corporate purchases and other methods.
Chinese biotech companies, including BGI Group and WuXi AppTec, are actively collecting genetic data, according to the US government, which has caused concern in the US.
Critics point to the unfair targeting of China, highlighting the possible consequences for the biotech supply chain and markets. However, despite concerns, the bill has every chance of being adopted.
The Chinese side, represented by Liu Pengyu, a representative of the Chinese Embassy in the United States, denies any accusations of stealing genetic data, calling them baseless and far-fetched.
Meanwhile, Republican Senator Rand Paul became the only U.S. official to vote against the bill, expressing the view that it uses anti-Chinese sentiment to achieve U.S. goals.
Thus, America needs to find a balance between protecting national security and remaining open to international cooperation in the field of biotechnology.
While it may be justified to restrict access to genetic data, excessive suspicion can harm scientific progress and global partnerships.
Only a reasonable approach, taking into account real threats, without excessive paranoia, will protect sensitive information and at the same time will not slow down the development of a promising industry.
